Professional
Added to YB: 2025-06-26
Pitch date: 2025-06-23
HIMS [neutral]
Hims & Hers Health, Inc.
-62.72%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$3.7B
Pitch Price
$42.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.63
P/E
30.31
EV/Sales
1.90
Sector
Health Care Providers and Services
Category
special_situation
HIMS Hold Rating Reaffirmed as Novo Exit Raises Legal, Traffic Headwinds
HIMS Hold: Novo Nordisk terminated partnership over concerns about 'illegal' compounding/marketing. Litigation risk now high (18-24mo potential overhang). Minimal revenue impact from branded Wegovy, but potential traffic decline affects compounding business. Est. weight loss = 33% of rev ($389M in 2H25), with $242M from compounding.
Read full article (2 min)